Market Value1,681,198,000
Total Holdings78
File Date2022-02-14
Original Filing (Click here)

All hedge funds or institutions that manage over $100M are required by the SEC to file quarterly reports on their holdings. These reports are called 13F reports. However, the filings are required the following quarter from the reporting period, which means that by the time the filing is made (and we see them), the information could be five months old.

For funds with long term positions that make few trades, the holdings might closely resemble their current holdings, even after several months. However, for funds that have high turnover, the holdings data we see might differ significantly from their current holdings. Institutions are required to report CALL and PUT options, and those positions are identified in the table. However, they are not required to report short positions.

Click the link icon to see the full transaction history.

Upgrade to unlock premium data and export to Excel .

Security Imputed
Share Price
Prev
Shares
Current
Shares
Change
(Percent)
Prev Value
(USD x1000)
Current Value
(USD x1000)
Change
(Percent)
ACET / Adicet Bio, Inc.
ANAB / AnaptysBio, Inc.
ORTX / Orchard Therapeutics plc - Depositary Receipt (Common Stock)
RXDX / Prometheus Biosciences Inc
RAIN / Rain Enhancement Technologies Holdco, Inc.
EWTX / Edgewise Therapeutics, Inc.
BEAM / Beam Therapeutics Inc.
CLDX / Celldex Therapeutics, Inc.
IGMS / IGM Biosciences, Inc.
SRNE / Sorrento Therapeutics, Inc.
MYOV / Myovant Sciences Ltd
ACRS / Aclaris Therapeutics, Inc.
CNTB / Connect Biopharma Holdings Limited - Depositary Receipt (Common Stock)
GLUE / Monte Rosa Therapeutics, Inc.
STOK / Stoke Therapeutics, Inc.
CHAQ / Chardan Healthcare Acquisition 2 Corp
BBIO / BridgeBio Pharma, Inc.
KROS / Keros Therapeutics, Inc.
OMER / Omeros Corporation
INSP / Inspire Medical Systems, Inc.
VERU / Veru Inc.
GOSS / Gossamer Bio, Inc.
ALXO / ALX Oncology Holdings Inc.
AKRO / Akero Therapeutics, Inc.
XFOR / X4 Pharmaceuticals, Inc.
OTLK / Outlook Therapeutics, Inc.
BCEL / Atreca, Inc.
CYTK / Cytokinetics, Incorporated
OLMA / Olema Pharmaceuticals, Inc.
BCAB / BioAtla, Inc.
VTYX / Ventyx Biosciences, Inc.
QURE / uniQure N.V.
GHRS / GH Research PLC
MRUS / Merus N.V.
RCKT / Rocket Pharmaceuticals, Inc.
SONX / Sonendo, Inc.
ASND / Ascendis Pharma A/S - Depositary Receipt (Common Stock)
QTNT / Quotient Ltd
MGTA / Magenta Therapeutics Inc
AGEN / Agenus Inc.
RETA / Reata Pharmaceuticals Inc - Class A
DCPH / Deciphera Pharmaceuticals, Inc.
DTIL / Precision BioSciences, Inc.
DMTK / DermTech, Inc.
IMAB / I-Mab - Depositary Receipt (Common Stock)
TVTX / Travere Therapeutics, Inc.
NERV / Minerva Neurosciences, Inc.
APTO / Aptose Biosciences Inc.
TCRR / Tcr2 Therapeutics Inc
BPMC / Blueprint Medicines Corporation
ZYME / Zymeworks Inc.
VECT / VectivBio Holding AG
FMTX / Forma Therapeutics Holdings Inc
ICVX / Icosavax, Inc.
ALGS / Aligos Therapeutics, Inc.
ELDN / Eledon Pharmaceuticals, Inc.
ITOS / iTeos Therapeutics, Inc.
AKUS / Akouos Inc
TYRA / Tyra Biosciences, Inc.
GRPH / Graphite Bio, Inc.
CCXI / ChemoCentryx Inc
IMV / IMV Inc
AVIR / Atea Pharmaceuticals, Inc.
GLTO / Galecto, Inc.
PLRX / Pliant Therapeutics, Inc.
RVMD / Revolution Medicines, Inc.
ATXS / Astria Therapeutics, Inc.
MORF / Morphic Holding, Inc.
ERAS / Erasca, Inc.
MLTX / MoonLake Immunotherapeutics
RNA / Avidity Biosciences, Inc.
PHVS / Pharvaris N.V.
PRAX / Praxis Precision Medicines, Inc.
CNTA / Centessa Pharmaceuticals plc - Depositary Receipt (Common Stock)
BMEA / Biomea Fusion, Inc.
MRTX / Mirati Therapeutics, Inc.
VRDN / Viridian Therapeutics, Inc.
ELEV / Elevation Oncology, Inc.
TALS / Talaris Therapeutics Inc
MGTX / MeiraGTx Holdings plc
PYXS / Pyxis Oncology, Inc.
AVTE / Aerovate Therapeutics, Inc.
DSGN / Design Therapeutics, Inc.
HARP / Harpoon Therapeutics, Inc.
TNGX / Tango Therapeutics, Inc.
VERV / Verve Therapeutics, Inc.
AMAM / Ambrx Biopharma Inc.
TPTX / Turning Point Therapeutics Inc
AUTL / Autolus Therapeutics plc - Depositary Receipt (Common Stock)
AXNX / Axonics, Inc.
IMRX / Immuneering Corporation
CABA / Cabaletta Bio, Inc.
TARS / Tarsus Pharmaceuticals, Inc.
YMAB / Y-mAbs Therapeutics, Inc.
APLS / Apellis Pharmaceuticals, Inc.
LBPH / Longboard Pharmaceuticals, Inc.